ECOG-ACRIN EA5152

Primary Category:

Treatment Protocols

Disease Category:

Lung, Lung - Non-Small Cell, Lung - Non-Small Cell Metastatic

Status:

Closed

A Randomized Phase II Trial of Nivolumab, Cabozantinib Plus Nivolumab, and Cabozantinib Plus Nivolumab Plus Ipilimumab in Patients with Previously Treated Non-Squamous NSCLC

NCT#03468985

Effective May 31st, 2019,  EA5152 is closed to accrual while the redesign developed for chemo/immunotherapy refractory patients will be opened as a new trial.